Breaking News Instant updates and real-time market news.

APO

Apollo Global

$42.86 /

-1.125 (-2.56%)

, WIMHY

William Hill

$0.00 /

+ (+0.00%)

07:52
09/25/20
09/25
07:52
09/25/20
07:52

Apollo approached William Hill to discuss buyout, Bloomberg reports

Apollo Global Management (APO) has approached U.K. gambling company William Hill (WMIHY) to discuss a potential takeover, Bloomberg reports, citing people familiar with the matter. Deliberations are at an early stage, and there's no certainty they will lead to a transaction, the sources added. Other names in the gambling space include Boyd Gaming (BYD), Caesars (CZR), Churchill Downs (CHDN), DraftKings (DKNG), Flutter Entertainment (PDYPY), Gan Limited (GAN), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN) and Wynn Resorts (WYNN). Reference Link

APO

Apollo Global

$42.86 /

-1.125 (-2.56%)

WIMHY

William Hill

$0.00 /

+ (+0.00%)

BYD

Boyd Gaming

$28.18 /

+0.49 (+1.77%)

MGM

MGM Resorts

$21.20 /

-0.185 (-0.87%)

CZR

Caesars

$52.79 /

-1.98 (-3.62%)

CHDN

Churchill Downs

$148.41 /

-16.01 (-9.74%)

PENN

Penn National

$64.05 /

-5.05 (-7.31%)

WYNN

Wynn Resorts

$71.04 /

+0.39 (+0.55%)

LVS

Las Vegas Sands

$45.90 /

+0.88 (+1.95%)

GAN

Gan Limited

$15.10 /

-0.02 (-0.13%)

PDYPY

Flutter Entertainment

$0.00 /

+ (+0.00%)

DKNG

DraftKings

$50.58 /

+0.48 (+0.96%)

  • 02

    Nov

  • 26

    Nov

  • 05

    May

  • 12

    May

  • 19

    Jun

  • 25

    Sep

APO Apollo Global
$42.86 /

-1.125 (-2.56%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
WIMHY William Hill
$0.00 /

+ (+0.00%)

09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
09/08/20 Barclays
William Hill price target raised to 240 GBp from 200 GBp at Barclays
BYD Boyd Gaming
$28.18 /

+0.49 (+1.77%)

09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Boyd Gaming price target raised to $35 from $33 at Macquarie
09/09/20 JPMorgan
Boyd Gaming price target raised to $40 from $30 at JPMorgan
08/28/20 Union Gaming
Boyd Gaming upgraded to Buy from Hold at Union Gaming
MGM MGM Resorts
$21.20 /

-0.185 (-0.87%)

09/24/20 Macquarie
MGM Resorts price target raised to $30 from $27 at Macquarie
09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 Roth Capital
MGM Resorts downgraded to Neutral from Buy at Roth Capital
CZR Caesars
$52.79 /

-1.98 (-3.62%)

09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
09/22/20 Roth Capital
Caesars value creation of $38/share through spinoff likely this year, says Roth
09/22/20 Deutsche Bank
Caesars price target raised to $65 from $50 at Deutsche Bank
CHDN Churchill Downs
$148.41 /

-16.01 (-9.74%)

09/25/20 Susquehanna
Susquehanna upgrades Churchill Downs to Positive on court ruling selloff
09/10/20
Fly Intel: Top five analyst downgrades
09/10/20 Jefferies
Jefferies cuts Churchill Downs to Hold after outperformance, ups target to $191
09/10/20 Jefferies
Churchill Downs downgraded to Hold from Buy at Jefferies
PENN Penn National
$64.05 /

-5.05 (-7.31%)

09/24/20
Fly Intel: Top five analyst downgrades
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
WYNN Wynn Resorts
$71.04 /

+0.39 (+0.55%)

09/16/20 Roth Capital
Wynn Resorts downgraded to Neutral from Buy at Roth Capital
09/10/20 Deutsche Bank
Wynn Resorts price target raised to $97 from $89 at Deutsche Bank
09/09/20 JPMorgan
Wynn Resorts price target raised to $101 from $98 at JPMorgan
09/06/20 Goldman Sachs
Wynn Resorts downgraded to Neutral from Conviction Buy at Goldman Sachs
LVS Las Vegas Sands
$45.90 /

+0.88 (+1.95%)

09/16/20 Roth Capital
Las Vegas Sands downgraded to Neutral from Buy at Roth Capital
09/10/20 Deutsche Bank
Las Vegas Sands price target raised to $60 from $54 at Deutsche Bank
GAN Gan Limited
$15.10 /

-0.02 (-0.13%)

08/21/20 B. Riley Securities
Gan selloff on FanDuel loss an overreaction, says B. Riley FBR
08/21/20 Craig-Hallum
Craig-Hallum says FanDuel migration a 'temporary blip' for Gan Limited
08/17/20 B. Riley Securities
DraftKings iGaming results positive for Gan Limited, says B. Riley FBR
08/12/20 Craig-Hallum
NJ sports betting up, iGaming revenue still strong, says Craig-Hallum
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

09/22/20 Morgan Stanley
Barstool Sportsbook app 'bullish' for the sector, says Morgan Stanley
09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Deutsche Bank
Flutter price target raised to 11,800 GBp from 10,200 GBp at Deutsche Bank
09/08/20 Barclays
Flutter Entertainment upgraded to Overweight from Equal Weight at Barclays
DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

09/25/20 Argus
DraftKings initiated with a Buy at Argus
09/25/20 Argus
DraftKings initiated with a Buy at Argus
09/24/20
Fly Intel: Top five analyst initiations
09/24/20 Macquarie
DraftKings initiated with an Outperform at Macquarie

TODAY'S FREE FLY STORIES

Periodicals
Apple Services business could be hit in Google antitrust battle, WSJ reports » 17:38
10/25/20
10/25
17:38
10/25/20
17:38
GOOG

Alphabet

$1,640.50 /

+25.89 (+1.60%)

, GOOGL

Alphabet Class A

$1,632.77 /

+24.75 (+1.54%)

, AAPL

Apple

$115.05 /

-0.77 (-0.66%)

The Justice…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

10/23/20 Cleveland Research
Alphabet upgraded to Buy on Search, Cloud momentum at Cleveland Research
10/22/20 Jefferies
Jefferies says 71% of Google users would still use search if removed from device
10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

10/23/20 Cleveland Research
Alphabet upgraded to Buy on Search, Cloud momentum at Cleveland Research
10/23/20 Cleveland Research
Alphabet Class A upgraded to Buy from Neutral at Cleveland Research
10/22/20 Jefferies
Jefferies says 71% of Google users would still use search if removed from device
10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
AAPL Apple
$115.05 /

-0.77 (-0.66%)

10/22/20 Cleveland Research
Cleveland Research sees further upside for Apple iPhone forecasts
10/22/20 DA Davidson
Apple 'looks good to us', says DA Davidson
10/22/20 Morgan Stanley
Apple iPhone12 cycle early data points trending positively, says Morgan Stanley
10/22/20 Piper Sandler
Apple price target raised to $135 from $130 at Piper Sandler
GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

Hot Stocks
Coca-Cola European Partners announces proposed acquisition of Coca-Cola Amatil » 17:19
10/25/20
10/25
17:19
10/25/20
17:19
CCEP

Coca-Cola European Partners

$39.00 /

-0.485 (-1.23%)

, CCLAY

Coca-Cola Amatil

$0.00 /

+ (+0.00%)

, KO

Coca-Cola

$50.52 /

-0.15 (-0.30%)

Coca-Cola European…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCEP Coca-Cola European Partners
$39.00 /

-0.485 (-1.23%)

KO Coca-Cola
$50.52 /

-0.15 (-0.30%)

CCEP Coca-Cola European Partners
$39.00 /

-0.485 (-1.23%)

07/06/20 ABN Amro
Coca-Cola European Partners upgraded to Buy from Hold at ABN Amro
06/22/20 Citi
Citi calls Coca-Cola European Partners its Top Pick in Beverages
06/10/20 ABN Amro
Coca-Cola European Partners upgraded to Hold from Sell at ABN Amro
06/05/20 HSBC
Coca-Cola European Partners initiated with a Hold at HSBC
CCLAY Coca-Cola Amatil
$0.00 /

+ (+0.00%)

10/21/20 JPMorgan
Coca-Cola Amatil upgraded to Overweight from Neutral at JPMorgan
08/06/20 Goldman Sachs
Coca-Cola Amatil upgraded to Buy from Neutral at Goldman Sachs
05/26/20 Goldman Sachs
Coca-Cola Amatil upgraded to Neutral from Sell at Goldman Sachs
05/26/20 Goldman Sachs
Coca-Cola Amatil upgraded to Neutral from Sell at Goldman Sachs
KO Coca-Cola
$50.52 /

-0.15 (-0.30%)

10/23/20 Morgan Stanley
Coca-Cola price target raised to $57 from $54 at Morgan Stanley
10/20/20 Jefferies
National Beverage upgraded to Hold on better La Croix market share at Jefferies
10/12/20 Citi
PepsiCo upgraded to Buy from Neutral at Citi
09/28/20 Morgan Stanley
PepsiCo trading at good entry point ahead of earnings, says Morgan Stanley
KO Coca-Cola
$50.52 /

-0.15 (-0.30%)

CCEP Coca-Cola European Partners
$39.00 /

-0.485 (-1.23%)

CCLAY Coca-Cola Amatil
$0.00 /

+ (+0.00%)

KO Coca-Cola
$50.52 /

-0.15 (-0.30%)

KO Coca-Cola
$50.52 /

-0.15 (-0.30%)

KO Coca-Cola
$50.52 /

-0.15 (-0.30%)

Periodicals
Amazon wins order to stall $3.4B Reliance-Future deal, Bloomberg says » 17:12
10/25/20
10/25
17:12
10/25/20
17:12
AMZN

Amazon.com

$3,203.69 /

+28.72 (+0.90%)

Amazon.com secured relief…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

10/20/20 Citi
Citi likes Amazon head of Q3 results despite Prime Day language
10/19/20 Piper Sandler
Amazon Prime Day sales up 49% year-over-year, says Piper Sandler
10/16/20 Citi
Citi questions if Amazon's Prime Day may disappoint compared to last year
10/15/20 Truist
Truist says indications show Amazon Prime Day again a 'record sales period'
AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

Periodicals
Carlyle nearing $2.4B deal for Siemen's Flender business, Bloomberg says » 17:09
10/25/20
10/25
17:09
10/25/20
17:09
CG

Carlyle Group

$27.50 /

-0.2 (-0.72%)

, SIEGY

Siemens

$0.00 /

+ (+0.00%)

Carlyle Group (CG) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CG Carlyle Group
$27.50 /

-0.2 (-0.72%)

SIEGY Siemens
$0.00 /

+ (+0.00%)

CG Carlyle Group
$27.50 /

-0.2 (-0.72%)

10/13/20 Citi
Carlyle Group upgraded to Buy from Neutral at Citi
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Carlyle Group downgraded to Neutral from Buy at Citi
04/15/20
Fly Intel: Top five analyst upgrades
SIEGY Siemens
$0.00 /

+ (+0.00%)

10/09/20 JPMorgan
Siemens Q4 numbers not likely an important catalyst, says JPMorgan
10/06/20 Vertical Research
Siemens upgraded to Buy from Hold at Vertical Research
10/02/20 UBS
Siemens price target lowered to EUR 122 from EUR 134 at UBS
09/29/20 Deutsche Bank
Siemens price target lowered to EUR 123 from EUR 135 at Deutsche Bank
CG Carlyle Group
$27.50 /

-0.2 (-0.72%)

SIEGY Siemens
$0.00 /

+ (+0.00%)

CG Carlyle Group
$27.50 /

-0.2 (-0.72%)

SIEGY Siemens
$0.00 /

+ (+0.00%)

CG Carlyle Group
$27.50 /

-0.2 (-0.72%)

SIEGY Siemens
$0.00 /

+ (+0.00%)

Periodicals
Dunkin' Brands near deal for $9B sale to Inspire Brands, NYTimes reports » 17:06
10/25/20
10/25
17:06
10/25/20
17:06
DNKN

Dunkin' Brands

$88.70 /

-0.5 (-0.56%)

Dunkin' Brands, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

10/23/20 KeyBanc
Dunkin' Brands price target raised to $97 from $78 at KeyBanc
10/20/20 Cleveland Research
Dunkin' Brands U.S. comps look to have improved, says Cleveland Research
10/19/20 Wells Fargo
Dunkin' Brands price target raised to $83 from $67 at Wells Fargo
10/06/20 Piper Sandler
Piper teen survey shows Snap, Amazon and Apple remain favorites
DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

Hot Stocks
Dunkin' Brands confirms preliminary discussions to be acquired by Inspire Brands » 16:51
10/25/20
10/25
16:51
10/25/20
16:51
DNKN

Dunkin' Brands

$88.70 /

-0.5 (-0.56%)

Dunkin' Brands, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

10/23/20 KeyBanc
Dunkin' Brands price target raised to $97 from $78 at KeyBanc
10/20/20 Cleveland Research
Dunkin' Brands U.S. comps look to have improved, says Cleveland Research
10/19/20 Wells Fargo
Dunkin' Brands price target raised to $83 from $67 at Wells Fargo
10/06/20 Piper Sandler
Piper teen survey shows Snap, Amazon and Apple remain favorites
DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

Recommendations
China Tesla car recall seems 'a pretty big deal,' says GLJ Research » 16:29
10/25/20
10/25
16:29
10/25/20
16:29
TSLA

Tesla

$420.61 /

-5.22 (-1.23%)

Commenting on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$420.61 /

-5.22 (-1.23%)

TSLA Tesla
$420.61 /

-5.22 (-1.23%)

10/23/20 Morgan Stanley
Tesla price target raised to $360 from $333 at Morgan Stanley
10/22/20
Fly Intel: Top five analyst upgrades
10/22/20 GLJ Research
GLJ keeps $40 target on Tesla, says business model not sustainable
10/22/20 RBC Capital
Tesla price target raised to $339 from $290 at RBC Capital
TSLA Tesla
$420.61 /

-5.22 (-1.23%)

  • 14
    Feb
TSLA Tesla
$420.61 /

-5.22 (-1.23%)

TSLA Tesla
$420.61 /

-5.22 (-1.23%)

TSLA Tesla
$420.61 /

-5.22 (-1.23%)

Earnings
SAP lowers FY20 revenue guidance to EUR 27.2-EUR 27.8B, from EUR 27.8B-EUR 28.5B » 16:21
10/25/20
10/25
16:21
10/25/20
16:21
SAP

SAP

$149.68 /

+2.15 (+1.46%)

SAP said in a statement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAP SAP
$149.68 /

+2.15 (+1.46%)

SAP SAP
$149.68 /

+2.15 (+1.46%)

10/08/20 JPMorgan
SAP expected to give Qualtrics update with Q3 results, says JPMorgan
07/28/20 JPMorgan
SAP price target raised to EUR 160 from EUR 125 at JPMorgan
07/28/20 Credit Suisse
SAP price target raised to EUR 157 from EUR 135 at Credit Suisse
07/28/20 BMO Capital
SAP price target raised to $170 from $130 at BMO Capital
SAP SAP
$149.68 /

+2.15 (+1.46%)

SAP SAP
$149.68 /

+2.15 (+1.46%)

SAP SAP
$149.68 /

+2.15 (+1.46%)

Earnings
Celanese expects FY20 adjusted EPS of $7-$7.10, consensus $6.99 » 16:16
10/25/20
10/25
16:16
10/25/20
16:16
CE

Celanese

$120.09 /

+2.065 (+1.75%)

"Across most of our…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CE Celanese
$120.09 /

+2.065 (+1.75%)

CE Celanese
$120.09 /

+2.065 (+1.75%)

10/19/20 Truist
Truist raises price targets in select Chemicals names
10/07/20 KeyBanc
Celanese upgraded to Overweight from Sector Weight at KeyBanc
10/07/20 KeyBanc
Celanese upgraded to Overweight from Sector Weight at KeyBanc
09/21/20 Evercore ISI
Celanese initiated with an Outperform at Evercore ISI
CE Celanese
$120.09 /

+2.065 (+1.75%)

CE Celanese
$120.09 /

+2.065 (+1.75%)

Earnings
Celanese reports Q3 adjusted EPS $1.95, consensus $1.70 » 16:14
10/25/20
10/25
16:14
10/25/20
16:14
CE

Celanese

$120.09 /

+2.065 (+1.75%)

Reports Q3 revenue $1.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CE Celanese
$120.09 /

+2.065 (+1.75%)

CE Celanese
$120.09 /

+2.065 (+1.75%)

10/19/20 Truist
Truist raises price targets in select Chemicals names
10/07/20 KeyBanc
Celanese upgraded to Overweight from Sector Weight at KeyBanc
10/07/20 KeyBanc
Celanese upgraded to Overweight from Sector Weight at KeyBanc
09/21/20 Evercore ISI
Celanese initiated with an Outperform at Evercore ISI
CE Celanese
$120.09 /

+2.065 (+1.75%)

CE Celanese
$120.09 /

+2.065 (+1.75%)

Hot Stocks
Mirati reports preliminary results from mutant KRAS selective inhibitor programs » 16:10
10/25/20
10/25
16:10
10/25/20
16:10
MRTX

Mirati Therapeutics

$180.37 /

+0.13 (+0.07%)

Mirati Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

10/21/20 BMO Capital
Mirati Therapeutics price target raised to $176 from $101 at BMO Capital
10/08/20 Credit Suisse
Mirati Therapeutics price target raised to $190 from $140 at Credit Suisse
09/28/20 BofA
Mirati Therapeutics initiated with a Neutral at BofA
09/28/20 BofA
Mirati Therapeutics initiated with a Neutral at BofA
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

  • 10
    Jan
Hot Stocks
Cenovus Energy, Husky Energy combine to create oil, natural gas company » 16:02
10/25/20
10/25
16:02
10/25/20
16:02
CVE

Cenovus Energy

$3.72 /

-0.03 (-0.80%)

Cenovus Energy and Husky…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

10/20/20 Morgan Stanley
Cenovus Energy price target lowered to C$6 from C$8 at Morgan Stanley
10/16/20 National Bank
Cenovus Energy price target lowered to C$8 from C$11 at National Bank
10/01/20
Fly Intel: Top five analyst downgrades
10/01/20 JPMorgan
Cenovus downgraded to Underweight on valuation, leverage at JPMorgan
CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

Hot Stocks
Essa Pharma presents therapeutics potential of EPI-7386 » 15:55
10/25/20
10/25
15:55
10/25/20
15:55
EPIX

Essa Pharma

$6.20 /

-0.26 (-4.02%)

Essa Pharma presented new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EPIX Essa Pharma
$6.20 /

-0.26 (-4.02%)

  • 29
    Jul
Hot Stocks
Lianluo Smart Limited, Newegg announce entering into merger agreement » 15:52
10/25/20
10/25
15:52
10/25/20
15:52
LLIT

Lianluo Smart Limited

$0.41 /

-0.0593 (-12.75%)

Lianluo Smart Limited and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLIT Lianluo Smart Limited
$0.41 /

-0.0593 (-12.75%)

Hot Stocks
Turning Point Therapeutics presents initial data from Phase 1 SHIELD-1 study » 15:46
10/25/20
10/25
15:46
10/25/20
15:46
TPTX

Turning Point Therapeutics

$102.72 /

+0.82 (+0.80%)

Turning Point…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
08/21/20 Canaccord
Turning Point Therapeutics price target raised to $85 from $80 at Canaccord
08/19/20 Roth Capital
Turning Point Therapeutics price target raised to $77 from $75 at Roth Capital
07/13/20 Roth Capital
Roth Capital positive on Turning Point Therapeutics appointment of Partridge
TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

  • 19
    May
Hot Stocks
Revolution Medicines reports progress, expansion of combo strategy with RMC-4630 » 15:39
10/25/20
10/25
15:39
10/25/20
15:39
RVMD

Revolution Medicines

$40.39 /

+1.17 (+2.98%)

, AZN

AstraZeneca

$52.01 /

+0.03 (+0.06%)

Revolution Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

  • 09
    Jul
  • 13
    Feb
AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

Hot Stocks
Syros presents initial data from Phase 1 trial of SY-5609 » 15:34
10/25/20
10/25
15:34
10/25/20
15:34
SYRS

Syros Pharmaceuticals

$7.55 /

+0.135 (+1.82%)

Syros Pharmaceuticals…

Syros Pharmaceuticals announced initial safety, pharmacokinetics and pharmacodynamics data from the ongoing dose-escalation portion of its Phase 1 clinical trial of SY-5609 in patients with select solid tumors. SY-5609 is a highly selective and potent oral cyclin-dependent kinase 7 inhibitor. These early data demonstrate proof of mechanism in patients with advanced solid tumors and establish a maximum tolerated dose for continuous daily dosing. The data was presented in a poster session at the 32nd EORTC-NCI-AACR Symposium. The study also includes a cohort evaluating SY-5609 in combination with fulvestrant in CDK4/6 inhibitor-resistant HR-positive breast cancer patients. As of August 21, 17 patients had been enrolled in the trial and were eligible for safety, PK and PD analysis. Patients were either treated with continuous daily dosing of single-agent SY-5609 at 1, 3, 4 or 5 mg, or for three weeks on and one week off at 3 mg in combination with fulvestrant. The median age of the patients enrolled in the study was 64. Patients were heavily pretreated with a median of four prior therapies. The MTD for continuous daily dosing was achieved at 3 mg. The data showed that SY-5609 demonstrated dose-dependent increases in POLR2A mRNA expression, a PD marker being used in the trial to measure CDK7 biological activity. Notably, increases in POLR2A in patients treated at 3 mg daily reached levels associated with tumor regressions in preclinical models, as well as with levels of CDK7 target engagement at which a clinical response and apoptosis were observed in a trial of patients treated with a first-generation IV CDK7 inhibitor. SY-5609 demonstrated approximately dose-proportional PK as both a single agent and in combination, minimal accumulation with repeat dosing, and a steady state half-life compatible with once-daily dosing. The majority of adverse events reported with SY-5609 as a single agent were low grade. The most common AEs were nausea, diarrhea, fatigue, platelet count decrease, and vomiting. The safety profile of SY-5609 in combination with fulvestrant was consistent with that of single-agent SY-5609. Five of the 13 patients treated with single-agent SY-5609 were response evaluable, and of those, three achieved stable disease and two had progressive disease; one of the four patients treated in the combination cohort was response evaluable and had progressive disease. The Phase 1 trial continues to actively enroll patients with select solid tumors, including the recently expanded single-agent cohort in lung cancer patients and combination cohort in breast cancer patients, to further evaluate the 3 mg daily dose in focused patient populations. The trial has also been opened to patients with advanced pancreatic cancer, another tumor type that has demonstrated sensitivity to SY-5609 in preclinical models. Additional cohorts are evaluating alternate regimens, supported by preclinical data showing that intermittent regimens of SY-5609 induced tumor regressions. Syros expects to report additional dose-escalation data, including clinical activity data, in mid-2021.

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
$7.55 /

+0.135 (+1.82%)

SYRS Syros Pharmaceuticals
$7.55 /

+0.135 (+1.82%)

09/22/20 Alliance Global Partners
Syros Pharmaceuticals initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
08/06/20 JMP Securities
Syros Pharmaceuticals price target raised to $20 from $16 at JMP Securities
08/06/20 Piper Sandler
Syros Pharmaceuticals price target raised to $18 from $14 at Piper Sandler
SYRS Syros Pharmaceuticals
$7.55 /

+0.135 (+1.82%)

Hot Stocks
Aileron announces proof-of-concept data from ALRN-6924 Phase 1b trial » 15:31
10/25/20
10/25
15:31
10/25/20
15:31
ALRN

Aileron Therapeutics

$1.92 /

-0.19 (-9.00%)

Aileron Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

06/05/20 H.C. Wainwright
Aileron Therapeutics price target lowered to $2 from $3 at H.C. Wainwright
05/27/20 JonesTrading
JonesTrading sees potential positive myelopreservation data in June for Aileron
04/08/20 JonesTrading
Aileron Therapeutics initiated with a Buy at JonesTrading
04/08/20 JonesTrading
Aileron Therapeutics initiated with a Buy at JonesTrading
ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

  • 04
    Jun
Hot Stocks
Momo announces Yan Tang as Executive Chairman, Li Wang as new CEO » 15:13
10/25/20
10/25
15:13
10/25/20
15:13
MOMO

Momo

$15.22 /

+0.56 (+3.82%)

Momo announced that its…

Momo announced that its board of directors has approved Yan Tang to step down from the position of Chief Executive Officer, and promoted Li Wang to this position, effective on November 1, 2020. Wang is a director of the Company, currently serving as the President and Chief Operating Officer of Momo. Starting from November 1, 2020, Yan Tang will become the executive chairman of the board of directors of Momo, in which role he will continue to be integrally involved in setting the strategic priorities and directing new business initiatives for Momo.

ShowHide Related Items >><<
MOMO Momo
$15.22 /

+0.56 (+3.82%)

09/04/20
Fly Intel: Top five analyst initiations
09/04/20
Fly Intel: Top five analyst downgrades
09/04/20 86 Research
Momo initiated with a Buy at 86 Research
09/04/20 Morgan Stanley
Momo downgraded to Equal Weight on core business risk at Morgan Stanley
MOMO Momo
$15.22 /

+0.56 (+3.82%)

MOMO Momo
$15.22 /

+0.56 (+3.82%)

MOMO Momo
$15.22 /

+0.56 (+3.82%)

Conference/Events
RenovaCare to host conference call » 12:31
10/25/20
10/25
12:31
10/25/20
12:31
RCAR

RenovaCare

$0.00 /

+ (+0.00%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCAR RenovaCare
$0.00 /

+ (+0.00%)

Conference/Events
Koppers Holdings to host conference call » 12:26
10/25/20
10/25
12:26
10/25/20
12:26
KOP

Koppers Holdings

$25.17 /

+0.67 (+2.73%)

Conference call to…

Conference call to provide a business update for August 2020 will be held on October 26 at 11 am. Webcast Link

ShowHide Related Items >><<
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
02/28/20 Barrington
Koppers Holdings price target lowered to $43 from $50 at Barrington
11/11/19 Barrington
Koppers Holdings price target raised to $50 from $35 at Barrington
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

Upgrade
PTT Exploration upgraded to Neutral from Sell at Goldman Sachs » 12:18
10/25/20
10/25
12:18
10/25/20
12:18
PEXNY

PTT Exploration

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEXNY PTT Exploration
$0.00 /

+ (+0.00%)

03/17/20 Nomura
PTT Exploration downgraded to Neutral from Buy at Nomura Instinet
Conference/Events
Aileron Therapeutics to host conference call » 11:33
10/25/20
10/25
11:33
10/25/20
11:33
ALRN

Aileron Therapeutics

$1.92 /

-0.19 (-9.00%)

Management will discuss…

Management will discuss the Company's presentation at the 32nd EORTC-NCI-AACR Virtual Symposium on a conference call to be held on October 26 at 8:30 am. Webcast Link

ShowHide Related Items >><<
ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

06/05/20 H.C. Wainwright
Aileron Therapeutics price target lowered to $2 from $3 at H.C. Wainwright
05/27/20 JonesTrading
JonesTrading sees potential positive myelopreservation data in June for Aileron
04/08/20 JonesTrading
Aileron Therapeutics initiated with a Buy at JonesTrading
04/08/20 JonesTrading
Aileron Therapeutics initiated with a Buy at JonesTrading
ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

  • 04
    Jun
On The Fly
Opening Day: McAfee returns to public market with $740M IPO » 08:19
10/25/20
10/25
08:19
10/25/20
08:19
INTC

Intel

$48.20 /

-5.78 (-10.71%)

, MFE

McAfee

$0.00 /

+ (+0.00%)

, FHTX

Foghorn Therapeutics

$18.07 /

+ (+0.00%)

, ABCM

Abcam

$18.90 /

-0.53 (-2.73%)

, GHLD

Guild Mortgage

$14.80 /

-0.2 (-1.33%)

, MSP

Datto

$28.94 /

+0.63 (+2.23%)

, YGMZ

MingZhu Logistics

$3.90 /

-0.25 (-6.02%)

, ACAC

Acies Acquisition

$0.00 /

+ (+0.00%)

, ATAC

Altimar Acquisition

$0.00 /

+ (+0.00%)

, EUCR

Eucrates Biomedical Acquisition

$0.00 /

+ (+0.00%)

, BLSA

BCLS Acquisition

$10.35 /

+0.2 (+1.97%)

, CTAC

Cerberus Telecom Acquisition

$0.00 /

+ (+0.00%)

, RICE

Rice Acquisition

$29.37 /

+ (+0.00%)

, SPNV

Supernova Partners Acquisition

$0.00 /

+ (+0.00%)

, SRSA

Sarissa Capital Acquisition

$0.00 /

+ (+0.00%)

, LFTR

Lefteris Acquisition

$0.00 /

+ (+0.00%)

, XPOA

DPCM Capital

$0.00 /

+ (+0.00%)

, HIGA

H.I.G. Acquisition

$0.00 /

+ (+0.00%)

, HLXA

Helix Acquisition

$10.50 /

-0.12 (-1.13%)

, GWAC

Good Works Acquisition

$0.00 /

+ (+0.00%)

, DCRB

Decarbonization Plus Acquisition

$0.00 /

+ (+0.00%)

, HZON

Horizon Acquisition Corp. II

$0.00 /

+ (+0.00%)

, AIRB

Airbnb

$0.00 /

+ (+0.00%)

, GMVD

G Medical Innovations

$0.00 /

+ (+0.00%)

, CMPX

Compass Therapeutics

$0.00 /

+ (+0.00%)

, HOMS

Caliber Home Loans

$0.00 /

+ (+0.00%)

, ROOT

Root

$0.00 /

+ (+0.00%)

, IKT

Inhibikase Therapeutics

$0.00 /

+ (+0.00%)

, LESL

Leslie's

$0.00 /

+ (+0.00%)

, MAX

MediaAlpha

$0.00 /

+ (+0.00%)

, ZG

Zillow

$96.73 /

-0.41 (-0.42%)

McAfee raised $740M in…

ShowHide Related Items >><<
ZG Zillow
$96.73 /

-0.41 (-0.42%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

10/23/20
Fly Intel: Top five analyst downgrades
10/23/20 Truist
Intel price target lowered to $51 from $61 at Truist
10/23/20 Jefferies
TSMC clearly has 'stronger hand' if Intel comes to negotiate, says Jefferies
10/23/20 JPMorgan
Intel price target lowered to $70 from $75 at JPMorgan
MFE McAfee
$0.00 /

+ (+0.00%)

FHTX Foghorn Therapeutics
$18.07 /

+ (+0.00%)

ABCM Abcam
$18.90 /

-0.53 (-2.73%)

GHLD Guild Mortgage
$14.80 /

-0.2 (-1.33%)

MSP Datto
$28.94 /

+0.63 (+2.23%)

YGMZ MingZhu Logistics
$3.90 /

-0.25 (-6.02%)

ACAC Acies Acquisition
$0.00 /

+ (+0.00%)

ATAC Altimar Acquisition
$0.00 /

+ (+0.00%)

EUCR Eucrates Biomedical Acquisition
$0.00 /

+ (+0.00%)

BLSA BCLS Acquisition
$10.35 /

+0.2 (+1.97%)

CTAC Cerberus Telecom Acquisition
$0.00 /

+ (+0.00%)

RICE Rice Acquisition
$29.37 /

+ (+0.00%)

SPNV Supernova Partners Acquisition
$0.00 /

+ (+0.00%)

SRSA Sarissa Capital Acquisition
$0.00 /

+ (+0.00%)

LFTR Lefteris Acquisition
$0.00 /

+ (+0.00%)

XPOA DPCM Capital
$0.00 /

+ (+0.00%)

HIGA H.I.G. Acquisition
$0.00 /

+ (+0.00%)

HLXA Helix Acquisition
$10.50 /

-0.12 (-1.13%)

GWAC Good Works Acquisition
$0.00 /

+ (+0.00%)

DCRB Decarbonization Plus Acquisition
$0.00 /

+ (+0.00%)

HZON Horizon Acquisition Corp. II
$0.00 /

+ (+0.00%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

GMVD G Medical Innovations
$0.00 /

+ (+0.00%)

CMPX Compass Therapeutics
$0.00 /

+ (+0.00%)

HOMS Caliber Home Loans
$0.00 /

+ (+0.00%)

ROOT Root
$0.00 /

+ (+0.00%)

IKT Inhibikase Therapeutics
$0.00 /

+ (+0.00%)

LESL Leslie's
$0.00 /

+ (+0.00%)

MAX MediaAlpha
$0.00 /

+ (+0.00%)

ZG Zillow
$96.73 /

-0.41 (-0.42%)

10/15/20 Piper Sandler
Zillow better positioned than Redfin into Q3 results, says Piper Sandler
10/14/20 Barclays
Zillow price target raised to $70 from $50 at Barclays
10/01/20 Jefferies
Zillow price target raised to $112 from $83 at Jefferies
10/01/20 Truist
Zillow price target raised to $115 from $108 at Truist
ZG Zillow
$96.73 /

-0.41 (-0.42%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

  • 30
    Oct
  • 29
    Oct
  • 29
    Oct
  • 30
    Oct
  • 28
    Oct
  • 28
    Oct
  • 23
    Oct
  • 22
    Oct
  • 22
    Oct
  • 21
    Oct
INTC Intel
$48.20 /

-5.78 (-10.71%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

ZG Zillow
$96.73 /

-0.41 (-0.42%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

On The Fly
Bet On It: Pennsylvania a battleground state for sportsbooks » 07:05
10/25/20
10/25
07:05
10/25/20
07:05
CZR

Caesars

$54.70 /

+0.53 (+0.98%)

, LVS

Las Vegas Sands

$50.69 /

+0.87 (+1.75%)

, DKNG

DraftKings

$42.79 /

-0.25 (-0.58%)

, PDYPY

Flutter Entertainment

$0.00 /

+ (+0.00%)

, MGM

MGM Resorts

$23.37 /

+0.74 (+3.27%)

, PENN

Penn National

$62.81 /

-0.93 (-1.46%)

Welcome to The Fly's…

ShowHide Related Items >><<
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

MGM MGM Resorts
$23.37 /

+0.74 (+3.27%)

LVS Las Vegas Sands
$50.69 /

+0.87 (+1.75%)

DKNG DraftKings
$42.79 /

-0.25 (-0.58%)

CZR Caesars
$54.70 /

+0.53 (+0.98%)

CZR Caesars
$54.70 /

+0.53 (+0.98%)

10/16/20 Morgan Stanley
Caesars price target raised to $68 from $54 at Morgan Stanley
10/08/20 Truist
DraftKings price target raised to $60 from $39 at Truist
10/05/20 Union Gaming
Caesars price target raised to $100 from $60 at Union Gaming
10/05/20 JPMorgan
Caesars price target raised to $67 from $63 at JPMorgan
LVS Las Vegas Sands
$50.69 /

+0.87 (+1.75%)

10/22/20 JPMorgan
Las Vegas Sands price target raised to $58 from $50 at JPMorgan
10/22/20 Stifel
Las Vegas Sands price target lowered to $60 from $64 at Stifel
10/20/20 JPMorgan
Las Vegas Sands price target lowered to $50 from $57 at JPMorgan
10/20/20 Deutsche Bank
Las Vegas Sands price target lowered to $58 from $60 at Deutsche Bank
DKNG DraftKings
$42.79 /

-0.25 (-0.58%)

10/15/20 Craig-Hallum
Strong results in NJ to encourage states to legalize iGaming, says Craig-Hallum
10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Benchmark
DraftKings price target raised to $60 from $57 at Benchmark
10/12/20 Oppenheimer
DraftKings price target raised to $65 from $55 at Oppenheimer
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

09/22/20 Morgan Stanley
Barstool Sportsbook app 'bullish' for the sector, says Morgan Stanley
09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Deutsche Bank
Flutter price target raised to 11,800 GBp from 10,200 GBp at Deutsche Bank
09/08/20 Barclays
Flutter Entertainment upgraded to Overweight from Equal Weight at Barclays
MGM MGM Resorts
$23.37 /

+0.74 (+3.27%)

10/12/20
Fly Intel: Top five analyst downgrades
10/12/20 Barclays
MGM Resorts downgraded to Underweight from Equal Weight at Barclays
10/05/20 Roth Capital
Macau numbers likely to go lower again, says Roth Capital
09/24/20 Truist
Truist raises price targets on select Gaming names
PENN Penn National
$62.81 /

-0.93 (-1.46%)

10/19/20 Rosenblatt
Barstool started strong in PA online sports betting, says Rosenblatt
10/12/20 Barclays
Penn National price target raised to $85 from $50 at Barclays
PENN Penn National
$62.81 /

-0.93 (-1.46%)

MGM MGM Resorts
$23.37 /

+0.74 (+3.27%)

LVS Las Vegas Sands
$50.69 /

+0.87 (+1.75%)

DKNG DraftKings
$42.79 /

-0.25 (-0.58%)

CZR Caesars
$54.70 /

+0.53 (+0.98%)

  • 07
    Oct
  • 29
    Sep
  • 25
    Sep
  • 19
    Jun
  • 12
    May
DKNG DraftKings
$42.79 /

-0.25 (-0.58%)

CZR Caesars
$54.70 /

+0.53 (+0.98%)

PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

LVS Las Vegas Sands
$50.69 /

+0.87 (+1.75%)

CZR Caesars
$54.70 /

+0.53 (+0.98%)

PENN Penn National
$62.81 /

-0.93 (-1.46%)

MGM MGM Resorts
$23.37 /

+0.74 (+3.27%)

LVS Las Vegas Sands
$50.69 /

+0.87 (+1.75%)

DKNG DraftKings
$42.79 /

-0.25 (-0.58%)

CZR Caesars
$54.70 /

+0.53 (+0.98%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.